May 15, 2016: Dr. W. Gasper Presents Clinical Case at the UCSF Vascular Symposium

Dr. Gasper presents a case study of a patient with persistent infiltration in an otherwise functional AV fistula. The ReTAP™ Patch was selected to resolve the bleeding condition and allow the fistula to be used for hemodialysis.

January 19, 2016: NSF Awards Solinas $500K SBIR Phase IIB Award

NSF awards Solinas the SBIR Phase IIB grant, a supplemental award to the Phase II grant. The objective of Phase IIB funding is to provide additional R&D funds to further accelerate commercialization of the Phase II project, when a qualifying third party financial investment/commitment has been received as a direct result of the NSF funded Phase I/Phase II research outcomes. The third party funding should serve to accelerate commercialization activity of the NSF funded Phase II Program.

February 21, 2014: Nikkiso Co. Ltd. Leads $2.25MM Series A Investment

Nikkiso is a conglomerate with a growing interest in expanding its medical product portfolio to address the $70 billion cost of managing 3.2 million people worldwide with end-stage renal disease. By forging a partnership with Nikkiso, Solinas aims to strengthen its ability to bring to market a first-in-class vascular protection system.

August 9, 2013: NSF Awards Solinas $500K SBIR Phase II Award

NSF awards Solinas the SBIR Phase II grant for the Company’s project entitled Application of a Durable Self-sealing Material for Hemodialysis Blood Access. The objective of SBIR Phase II awards are to continue the R&D efforts initiated in Phase I of the program with funding based on the results achieved in Phase I and the scientific and technical merit and commercial potential of the project proposed in Phase II.

December 7, 2012: SMI™ Cardiovascular Patch receives 510(k) clearance

FDA grants clearance for Solinas’ extended arc coverage cardiovascular patch.

December 14, 2011: SMI™ Cardiovascular Patch receives 510(k) clearance

FDA grants clearance for Solinas’ flat and curved cardiovascular patches.

November 17, 2011: NSF Awards Solinas $150K SBIR Phase I Award

The National Science Foundation awards Solinas the Phase I grant through the Small Business Innovation Research (SBIR) program for the Company’s project entitled Application of a Self-sealing Composite Structural Material for Hemodialysis Blood Access. The mission of the SBIR program is to support scientific excellence and technological innovation through the investment of federal research funds in critical American priorities. The objective of Phase I awards are to establish the technical merit, feasibility, and commercial potential of the proposed efforts and to determine the quality of performance of the small business awardee organization prior to providing further support.